Phase
Condition
Follicular Lymphoma
Lymphoma
Lymphoma, B-cell
Treatment
Radiation Therapy
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
primary indolent gastric or duodenal lymphoma
pathology: marginal zone lymphoma (MZL) or follicular lymphoma (FL)
stage: clinical stage I or II (Ann Arbor classification)
H. pylori negative or antibiotic resistant lymphoma
IPI or FLIPI score low - high (0-4)
any size of tumor or affected lymph nodes
male or female with age ≥ 18 years
performance status ECOG 0 - 3
written informed consent by the patient
Exclusion
Exclusion Criteria:
prior radiation treatment of the gastrointestinal lymphoma
stage: clinical stage III or IV (Ann Arbor classification)-unability to understandthe informed consent or unwillingness to participate in the study
severe comorbidity or organ dysfunction contraindicating the use of RT (livercirrhosis Child-Pugh C, chronic obstructive pulmonary disease GOLD 4, heartinsufficiency NYHA IV, dialysis dependent renal insufficiency, uncontrolledepilepsy)
known seropositivity for HIV
acute hepatitis B or C infection
chronic inflammatory bowel disease
prior malignant disease (exclusion: basalioma, non-metastasized solid tumor inconstant remission diagnosed >3 years ago)
pregnancy or breastfeeding
active substance abuse or severely compromised compliance
Study Design
Study Description
Connect with a study center
Department of Radiation Oncology
Münster, North Rhine-Westphalia 48149
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.